These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23537806)

  • 1. Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample.
    Mullen MT; Kasner SE; Kallan MJ; Kleindorfer DO; Albright KC; Carr BG
    J Am Heart Assoc; 2013 Mar; 2(2):e000071. PubMed ID: 23537806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers.
    Aparicio HJ; Carr BG; Kasner SE; Kallan MJ; Albright KC; Kleindorfer DO; Mullen MT
    J Am Heart Assoc; 2015 Oct; 4(10):e001877. PubMed ID: 26467999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis for acute ischemic stroke in Joint Commission-certified and -noncertified hospitals in Michigan.
    Rajamani K; Millis S; Watson S; Mada F; Salowich-Palm L; Hinton S; Chaturvedi S
    J Stroke Cerebrovasc Dis; 2013 Jan; 22(1):49-54. PubMed ID: 21852156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of Adverse Events and Outcomes among Stroke Patients Admitted to Primary Stroke Centers.
    Chaudhry SA; Afzal MR; Chaudhry BZ; Zafar TT; Safdar A; Kassab MY; Hussain SI; Qureshi AI
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1960-5. PubMed ID: 27209089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in rt-PA Utilization at Hospitals Treating Stroke: The National Inpatient Sample.
    Boehme AK; Carr BG; Kasner SE; Albright KC; Kallan MJ; Elkind MSV; Branas CC; Mullen MT
    Front Neurol; 2017; 8():500. PubMed ID: 29021776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after ischemic stroke for hospitals with and without Joint Commission-certified primary stroke centers.
    Lichtman JH; Jones SB; Wang Y; Watanabe E; Leifheit-Limson E; Goldstein LB
    Neurology; 2011 Jun; 76(23):1976-82. PubMed ID: 21543736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous thrombolysis for stroke increases over time at primary stroke centers.
    Prabhakaran S; McNulty M; O'Neill K; Ouyang B
    Stroke; 2012 Mar; 43(3):875-7. PubMed ID: 22135073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Acute Ischemic Stroke Quality of Care and Outcomes by Primary Stroke Center Certification Organization.
    Man S; Cox M; Patel P; Smith EE; Reeves MJ; Saver JL; Bhatt DL; Xian Y; Schwamm LH; Fonarow GC
    Stroke; 2017 Feb; 48(2):412-419. PubMed ID: 28008094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Stroke Center Certification on Mortality After Ischemic Stroke: The Medicare Cohort From 2009 to 2013.
    Man S; Schold JD; Uchino K
    Stroke; 2017 Sep; 48(9):2527-2533. PubMed ID: 28747463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Stroke Center Hospitalization for Elderly Patients With Stroke: Implications for Case Fatality and Travel Times.
    Bekelis K; Marth NJ; Wong K; Zhou W; Birkmeyer JD; Skinner J
    JAMA Intern Med; 2016 Sep; 176(9):1361-8. PubMed ID: 27455403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of stroke center certification on rt-PA thrombolysis after acute ischemic stroke in South China from 2015 to 2020.
    Chen Y; Li J; Dang C; Tan S; Ouyang F; Li J; Yu J; Zeng J; Fan Y
    Int J Stroke; 2022 Jun; 17(5):559-565. PubMed ID: 34235984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Stroke Center Certification on Thrombolysis Time Metrics in Telestroke Setting.
    Almallouhi E; Ajinkya S; Rahwan M; Holmstedt CA; Al Kasab S
    Telemed J E Health; 2021 Feb; 27(2):167-171. PubMed ID: 32397843
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of Acute Ischemic Stroke Care and Outcomes Between Comprehensive Stroke Centers and Primary Stroke Centers in the United States.
    Man S; Zhao X; Uchino K; Hussain MS; Smith EE; Bhatt DL; Xian Y; Schwamm LH; Shah S; Khan Y; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2018 Jun; 11(6):e004512. PubMed ID: 29794035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use and in-hospital outcomes of recombinant tissue plasminogen activator in pediatric arterial ischemic stroke patients.
    Nasr DM; Biller J; Rabinstein AA
    Pediatr Neurol; 2014 Nov; 51(5):624-31. PubMed ID: 25194722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue plasminogen activator (rt-PA) in acute ischemic stroke: Outcomes associated with ambulation.
    Lawson TR; Brown IE; Westerkam DL; Blackhurst DW; Sternberg S; Leacock R; Nathaniel TI
    Restor Neurol Neurosci; 2015; 33(3):301-8. PubMed ID: 25698111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke.
    Kleindorfer D; Xu Y; Moomaw CJ; Khatri P; Adeoye O; Hornung R
    Stroke; 2009 Nov; 40(11):3580-4. PubMed ID: 19797701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate.
    Kleindorfer D; Lindsell CJ; Brass L; Koroshetz W; Broderick JP
    Stroke; 2008 Mar; 39(3):924-8. PubMed ID: 18239184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pennsylvania comprehensive stroke center collaborative: Statement on the recently updated IV rt-PA prescriber information for acute ischemic stroke.
    Daou B; Deprince M; D'Ambrosio R; Tjoumakaris S; Rosenwasser RH; Ackerman DJ; Bell R; Tzeng DL; Ghobrial M; Fernandez A; Shah Q; Gzesh DJ; Murphy D; Castaldo JE; Mathiesen C; Pineda MC; Jabbour P
    Clin Neurol Neurosurg; 2015 Dec; 139():264-8. PubMed ID: 26539671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.